Phase I Randomized, Open-label, Parallel-controlled, Pharmacokinetic and Safety Study of BR201 Injection Versus Cosentyx in Healthy Male Subjects
Clinical trial NCT06126718 · COMPLETED
Trial details
- NCT number
- NCT06126718
- Sponsor
- BioRay Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-21
- Primary completion
- 2024-08-19
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.